MedTrace Logo

The DistaSense VITALS Study

NCT07217327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-11-03

No results posted yet for this study

Summary

A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.

Conditions

  • Detection of Heart Rate and Respiratory Rate

Interventions

DIAGNOSTIC_TEST

DistaSense and Polysomnography

All subjects will be evaluated by DistaSense and reference device for respiratory rate and heart rate.

Sponsors & Collaborators

  • Nilo Medical Consulting Group

    collaborator UNKNOWN

  • Life Detection Technologies

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-13
Primary Completion
2025-11-30
Completion
2025-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07217327 on ClinicalTrials.gov